معرفی
Professor Kevin Baird serves as Head of Unit at OUCRU Indonesia, a partnership between the University of Oxford and the Eijkman Institute for Molecular Biology, and holds the title of Professor of Malariology in the Nuffield Department of Medicine at Oxford. Based in Jakarta, he leads research on tropical infectious diseases with a primary focus on Plasmodium vivax malaria.
His research spans malaria diagnostics, therapeutics, and vector control, with particular emphasis on the challenges of treating vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient patients. He also investigates pharmacogenetic factors affecting drug metabolism and conducts clinical trials for malaria, tuberculosis meningitis, and cryptococcal meningitis.
Recent publications highlight a strong trend in vivax malaria research, including studies on primaquine treatment in children, biomarker development for drug activity monitoring, and vector control strategies. His work increasingly integrates systematic reviews and meta-analyses to inform treatment guidelines, while expanding into COVID-19 vaccine response studies in Indonesian populations.
OUCRU Indonesia, under Professor Baird's leadership, operates from the Eijkman Institute's facility in Jakarta and maintains extensive collaborations with Indonesian universities, the Ministry of Health, and the Indonesian Armed Forces. The unit has pioneered a unique soldier volunteer model for malaria relapse studies and actively engages in field research across Indonesia.
